Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Anticancer Bioscience logo — Applying our synthetic lethality expertise for better cancer...

Anticancer Bioscience

Applying our synthetic lethality expertise for better cancer therapies

Founded 2016 China Chengdu, China 17 employees Seed Total: $200.15M Biotechnology, Health Care +3

General Information

Company Name Anticancer Bioscience
Founded Year 2016
Location China Chengdu, China +4
Employees 17
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Seed
Social

Get notified when Anticancer Bioscience moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Anticancer Bioscience

Anticancer Bioscience (ACB) is a precision therapeutics company headquartered in Chengdu, China, with global research and development teams in India, the United Kingdom, and the United States. The company's focus lies in developing synthetic lethal therapies that address unmet medical needs in the field of Biotechnology, Health Care, Health and Wellness, Life Sciences, and the Pharmaceutical industry. At the forefront of ACB's offerings are their synthetic lethal therapies for cancer. Founded in 2016 by experts in identifying and exploiting cancer vulnerabilities, ACB has gathered a team of talented scientists dedicated to developing safe, effective, and broad-spectrum targeted therapies for cancers that are currently inaccessible or have become refractory to existing therapy. The company recently secured a CNY68.40M Seed Round investment on 14 October 2021 from 3 Rivers Capital, LLC. ACB's mission and dedication to developing innovative drugs in the oncology space positions it as a promising investment opportunity for Venture Capitalists seeking to support advancements in cancer treatment. For more information about ACB's pipeline of drugs and technology platforms, as well as potential partnership and employment opportunities, visit www.anticancerbio.com.

Taxonomy: Precision Therapeutics, Synthetic Lethal Therapies, Oncology Research, Cancer Vulnerabilities, Genetic Perturbations, Medicinal Chemistry, Drug Development, Targeted Therapies, Cancer Treatment Innovation, Global Research and Development, Employment Opportunities, Equal Opportunity Employer

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
14 Oct 2021
Seed Round •••••• - 08 Feb 2021
Seed Round •••••• - 01 Jan 2020

Anticancer Bioscience Alternatives & Competitors

Anticancer Bioscience vs
Advenchen Laboratories, LLC
Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...

Series Unknown
6 employees
Biotechnology, Health Care
Anticancer Bioscience vs
Elevation Oncology
Elevation Oncology United States

We are focused on discovering and developing selective cancer therapies to treat patients across a r...

Acquired
5 employees
Biopharma, Biotechnology
Anticancer Bioscience vs
Vicinitas Therapeutics
Vicinitas Therapeutics United States

Advancing a one-of-a-kind protein stabilization platform to develop novel therapeutics for cancer an...

Series A
4 employees
Biotechnology, Health and Wellness

FAQ About Anticancer Bioscience

Applying our synthetic lethality expertise for better cancer therapies
Anticancer Bioscience was founded in 2016.
Anticancer Bioscience is headquartered in Chengdu, China.
Anticancer Bioscience operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences, Pharmaceutical.
Anticancer Bioscience has approximately 17 employees.
Anticancer Bioscience has completed 3 funding rounds, raising a total of $200.15M. The latest funding stage is Seed.
Top alternatives and competitors to Anticancer Bioscience include Advenchen Laboratories, LLC, Elevation Oncology, Vicinitas Therapeutics, Apollomics, Prescient Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Anticancer Bioscience and Advenchen Laboratories, LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Anticancer Bioscience and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes